Mechanisms	mechanisms	O	O	O	O
of	of	O	O	O	O
FK	fk	O	O	O	O
506-induced	506-induced	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
rat.-Tacrolimus	rat.-tacrolimus	O	O	O	O
(	(	O	O	O	O
FK	fk	CHEMICALS	O	OTHERS	I
506	506	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
is	is	O	O	O	O
a	a	O	O	O	O
powerful	powerful	O	O	O	O
,	,	O	O	O	O
widely	widely	O	O	O	O
used	used	O	O	O	O
immunosuppressant	immunosuppressant	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
clinical	clinical	O	O	O	O
utility	utility	O	O	O	O
of	of	O	O	O	O
FK	fk	CHEMICALS	O	OTHERS	I
506	506	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
complicated	complicated	O	O	O	O
by	by	O	O	O	O
substantial	substantial	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
and	and	O	O	O	O
nephrotoxicity	nephrotoxicity	O	DISEASE	OTHERS	I
.	.	O	O	O	O

To	to	O	O	O	O
clarify	clarify	O	O	O	O
the	the	O	O	O	O
mechanisms	mechanisms	O	O	O	O
of	of	O	O	O	O
FK	fk	O	O	O	O
506-induced	506-induced	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
,	,	O	O	O	O
we	we	O	O	O	O
studied	studied	O	O	O	O
the	the	O	O	O	O
chronic	chronic	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
FK	fk	CHEMICALS	O	OTHERS	I
506	506	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
the	the	O	O	O	O
synthesis	synthesis	O	O	O	O
of	of	O	O	O	O
endothelin-1	endothelin-1	O	O	O	O
(	(	O	O	O	O
ET-1	et-1	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
expression	expression	O	O	O	O
of	of	O	O	O	O
mRNA	mrna	O	O	O	O
of	of	O	O	O	O
ET-1	et-1	O	O	O	O
and	and	O	O	O	O
endothelin-converting	endothelin-converting	O	O	O	O
enzyme-1	enzyme-1	O	O	O	O
(	(	O	O	O	O
ECE-1	ece-1	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
endothelial	endothelial	O	O	O	O
nitric	nitric	CHEMICALS	O	OTHERS	I
oxide	oxide	CHEMICALS	O	OTHERS	I
synthase	synthase	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
eNOS	enos	O	O	O	O
)	)	O	O	O	O
activity	activity	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
expression	expression	O	O	O	O
of	of	O	O	O	O
mRNA	mrna	O	O	O	O
of	of	O	O	O	O
eNOS	enos	O	O	O	O
and	and	O	O	O	O
C-type	c-type	O	O	O	O
natriuretic	natriuretic	O	O	O	O
peptide	peptide	O	O	O	O
(	(	O	O	O	O
CNP	cnp	O	O	O	O
)	)	O	O	O	O
in	in	O	O	O	O
rat	rat	O	O	O	O
blood	blood	O	O	O	O
vessels	vessels	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
addition	addition	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
specific	specific	O	O	O	O
endothelin	endothelin	O	O	O	O
type	type	O	O	O	O
A	a	O	O	O	O
receptor	receptor	O	O	O	O
antagonist	antagonist	O	O	O	O
FR	fr	CHEMICALS	O	OTHERS	I
139317	139317	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
FK	fk	O	O	O	O
506-induced	506-induced	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
in	in	O	O	O	O
rats	rats	O	O	O	O
was	was	O	O	O	O
studied	studied	O	O	O	O
.	.	O	O	O	O

FK	fk	CHEMICALS	O	OTHERS	I
506	506	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
5	5	O	O	O	O
mg	mg	O	O	OTHERS	I
.	.	O	O	O	O

kg-1	kg-1	O	O	O	O
.	.	O	O	O	O

d-1	d-1	O	O	O	O
given	given	O	O	O	O
for	for	O	O	O	O
4	4	O	O	O	O
weeks	weeks	O	O	O	O
,	,	O	O	O	O
elevated	elevated	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
from	from	O	O	O	O
102+/-13	102+/-13	O	O	O	O
to	to	O	O	O	O
152+/-15	152+/-15	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
and	and	O	O	O	O
increased	increased	O	O	O	O
the	the	O	O	O	O
synthesis	synthesis	O	O	O	O
of	of	O	O	O	O
ET-1	et-1	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
ET-1	et-1	O	O	O	O
mRNA	mrna	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
mesenteric	mesenteric	O	O	O	O
artery	artery	O	O	O	O
(	(	O	O	O	O
240	240	O	O	O	O
%	%	O	O	O	O
and	and	O	O	O	O
230	230	O	O	O	O
%	%	O	O	O	O
,	,	O	O	O	O
respectively	respectively	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Little	little	O	O	O	O
change	change	O	O	O	O
was	was	O	O	O	O
observed	observed	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
expression	expression	O	O	O	O
of	of	O	O	O	O
ECE-1	ece-1	O	O	O	O
mRNA	mrna	O	O	O	O
and	and	O	O	O	O
CNP	cnp	O	O	O	O
mRNA	mrna	O	O	O	O
.	.	O	O	O	O

FK	fk	CHEMICALS	O	OTHERS	I
506	506	CHEMICALS	O	OTHERS	I
decreased	decreased	O	O	O	O
eNOS	enos	O	O	O	O
activity	activity	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
eNOS	enos	O	O	O	O
mRNA	mrna	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
aorta	aorta	O	O	O	O
(	(	O	O	O	O
48	48	O	O	O	O
%	%	O	O	O	O
and	and	O	O	O	O
55	55	O	O	O	O
%	%	O	O	O	O
,	,	O	O	O	O
respectively	respectively	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
FR	fr	CHEMICALS	O	OTHERS	I
139317	139317	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
10	10	O	O	O	O
mg	mg	O	O	OTHERS	I
.	.	O	O	O	O
kg-1	kg-1	O	O	O	O
.	.	O	O	O	O

d-1	d-1	O	O	O	O
)	)	O	O	O	O
prevented	prevented	O	O	O	O
FK	fk	O	O	O	O
506-induced	506-induced	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
in	in	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
results	results	O	O	O	O
indicate	indicate	O	O	O	O
that	that	O	O	O	O
FK	fk	CHEMICALS	O	OTHERS	I
506	506	CHEMICALS	O	OTHERS	I
may	may	O	O	O	O
increase	increase	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
not	not	O	O	O	O
only	only	O	O	O	O
by	by	O	O	O	O
increasing	increasing	O	O	O	O
ET-1	et-1	O	O	O	O
production	production	O	O	O	O
but	but	O	O	O	O
also	also	O	O	O	O
by	by	O	O	O	O
decreasing	decreasing	O	O	O	O
NO	no	O	O	O	O
synthesis	synthesis	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
vasculature	vasculature	O	O	O	O
.	.	O	O	O	O

